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Abstract
Background: Stroke and other non-communicable diseases are important emerging public health concerns in
sub-Saharan Africa where stroke-related mortality and morbidity are higher compared to other parts of the world.
Despite the availability of evidence-based acute stroke interventions globally, uptake in low-middle income countries
(LMIC) such as Ghana is uncertain. This study aimed to identify and evaluate available acute stroke services in Ghana
and the extent to which these services align with global best practice.
Methods: A multi-site, hospital-based survey was conducted in 11 major referral hospitals (regional and tertiary - teaching
hospitals) in Ghana from November 2015 to April 2016. Respondents included neurologists, physician specialists
and medical officers (general physicians). A pre-tested, structured questionnaire was used to gather data on available
hospital-based acute stroke services in the study sites, using The World Stroke Organisation Global Stroke Services
Guideline as a reference for global standards.
Results: Availability of evidence-based services for acute stroke care in the study hospitals were varied and limited. The
results showed one tertiary-teaching hospital had a stroke unit. However, thrombolytic therapy (thrombolysis) using
recombinant tissue plasminogen activator for acute ischemic stroke care was not available in any of the study
hospitals. Aspirin therapy was administered in all the 11 study hospitals. Although eight study sites reported
having a brain computed tomographic (CT) scan, only 7 (63.6%) were functional at the time of the study.
Magnetic resonance imaging (MRI scan) services were also limited to only 4 (36.4%) hospitals (only functional in three).
Acute stroke care by specialists, especially neurologists, was found in 36.4% (4) of the study hospitals whilst none of the
study hospitals had an occupational or a speech pathologist to support in the provision of acute stroke care.
Conclusion: This study confirms previous reports of limited and variable provision of evidence based stroke services
and the low priority for stroke care in resource poor settings. Health policy initiatives to enhance uptake of evidence-
based acute stroke services is required to reduce stroke-related mortality and morbidity in countries such as Ghana.
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Background
Stroke remains the second leading cause of deaths
globally, recording a 26% increase in stroke deaths
between 1990 and 2010 [1]. According to the World
Stroke Society campaign highlights, one in six people
in the world will suffer a stroke in their life time [2].
In Africa and other LMIC, stroke and other non-
communicable diseases have become a great public
health concern as current evidence suggests such set-
tings are disproportionately affected by the overall
global burden of stroke [3–5]. For example, of the es-
timated 5.9 million deaths linked to stroke worldwide
in 2010, 71% were from LMIC settings [1]. Re-
searchers further suggested that whereas high-income
countries (HIC) show significant reductions in stroke
incidence of about 42% over the last 40 years, a 100%
increase in stroke incidence occurred in LMIC over
the same period [6].
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In Ghana, several studies have also confirmed an in-
creasing stroke burden, with one month in-hospital case
fatality as high as 41–43% [7–10]. For example, one of
such studies examined a total of 12,233 stroke admis-
sions over a 30 years period (1983–2013) and found that
28 day mortality during the study period was 41.1% [8].
In addition, the US Centres for Disease Control and Pre-
vention (CDC) has reported that stroke is the fourth
cause of mortality in Ghana [11]. These relatively high
rates of in-hospital mortality raise important questions
about the nature of acute stroke services in Ghana.
Based on the current epidemiological transition attrib-
uted to aging populations, urbanization and modifiable
stroke risk factors [12, 13] the future burden of stroke is
substantial in LMIC [14], and inevitably, there will be an
increased demand for acute stroke care interventions.
The World Health Organisation (WHO) has previously
asserted that the current stroke mortality burden in
LMIC such as Ghana can be attenuated by the provision
of quality and standardised stroke care [15], highlighting
the need to ensure increased uptake to evidence-based
stroke care interventions in such settings.
Despite the concept of evidence-based medicine is
highly contested and has been diversely conceptualised
[16, 17], the definition by Sackett et al. is widely acclaimed
and accepted among medical researchers and practitioners
[18]. The authors defined evidence-based medicine as ‘the
conscientious, explicit, and judicious use of current best
evidence in making decisions about the care of individual
patients as well as integrating individual clinical expertise
with the best available external clinical evidence from sys-
tematic research’. Thus, evidence-based acute stroke care
interventions in this context refer to those interventions
which are guided by sound scientific evidence, are well
consistent with the clinical judgement and expertise of the
individual clinician and meet the needs of patients for im-
proved clinical outcomes.
Internationally, there is consistent body of evidence
that stroke patients treated a) in a stroke unit by a multi-
disciplinary care team [19], b) using thrombolytic ther-
apy through tissue plasminogen activator (t-PA) for
acute ischemic stroke care patients within 4.5 h of stroke
onset [20, 21], c) administering of aspirin for ischemic
acute ischemic stroke patients within 48 h of a stroke
[22], and d) decompressive surgery within 48 h of an
acute stroke [23, 24] have reduced stroke-related mortal-
ity and morbidity. To support health systems worldwide
especially of poor resource settings with high stroke bur-
den to be able to consistently provide standard care for
improved patient outcomes, a stroke services guideline
by the World Stroke Organisation was developed [25].
Despite clear demonstration of the effectiveness of
these evidence-based interventions for acute stroke care,
there is widespread variation and limited uptake globally
and this is substantially lower in LMIC such as Ghana
[26–28]. The World Stroke Society has consequently
prioritised access to evidence-based stroke care as a key
theme in their 2016 global campaign, emphasizing the
importance of this study. The slow uptake of evidence-
based stroke care interventions is underpinned by multi-
factorial barriers at the health system, patient, health
care providers and nature of acute stroke interventions
levels [29–31].
To date, research on the availability of evidence-based
acute stroke care interventions in hospital settings globally
has been limited to high income countries. The UK,
Australia, Canada and some European countries are ex-
emplars [32–35]. Conversely, there is little information on
evidence-based acute stroke services in Africa and other
resource-poor settings. From the few studies available, the
use of evidence-based acute stroke care services in LMIC
settings is often asserted to be limited, poor and less likely
to follow best practice guidelines [26–28, 36, 37]. An im-
mediate question of public health interest will be to what
extent are evidence-based acute stroke care interventions
provided to acute stroke patients in the hospitals of LMIC
such as Ghana? Addressing this question has the potential
to provide baseline information on available evidence-
based acute stroke care interventions and as well identify
gaps in current stroke services which could support the
development of future interventions seeking to stand-
ardise and improve acute stroke care services for opti-
mal patient outcomes. This study therefore aims to
identify available acute stroke services in Ghana and to
evaluate the extent to which these services align with
global best practice.
Methods
Study design and settings
This is descriptive study involving a survey conducted in
major referral hospitals in all the ten administrative re-
gions of Ghana to collect data on available acute stroke
services from key acute stroke care providers between
November 2015 and April 2016.
Ghana has a multi-health care system with the in-
volvement of both public and private health care pro-
viders where healthcare delivery is provided by the
formal medical healthcare system, faith-based health
care system and the services from the ethno-medical
system [38]. Of these, there are tertiary-teaching hospi-
tals, regional hospitals, psychiatric hospitals, district hos-
pitals and subdistrict health centres in the public sector
[39]. However, the district hospitals and sub-district
health centres often have limited clinical capacity for
stroke care and so were excluded in this study. This
study therefore purposively sampled only major public
referral hospitals representing four of the five teaching
hospitals as well as seven of the nine regional hospitals
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in Ghana. Except for one region (Greater Accra) where
it was convenient to collect data from two major referral
hospitals (one regional and one tertiary hospital), data
was collected from either tertiary teaching or regional
hospital which acted as the primary referral hospital in
that particular administrative region. In spite of differ-
ences in the clinical capacities of the study hospitals on
the basis of their status as a tertiary-teaching or regional
hospital, these hospitals were chosen because they act as
major referral hospitals for other hospitals and health
centres in each of the ten administrative regions. Unlike
the seven regional hospitals, the tertiary teaching hospi-
tals serve as larger referral centres and are better-
resourced with diagnostic and therapeutic facilities. They
also serve as tertiary academic centres offering training
in a range of highly specialised clinical disciplines. As
presented in Table 1, the overall hospital bed capacity
for admissions in the study sites ranged from 150 to 653
with annual stroke admissions for 2014 within the range
of 49 to 1500 stroke cases per hospital.
Study participants
Respondents comprised neurologists, medical officers
(general physicians) and physician specialists. These key
informants were targeted because: they have relevant
knowledge or expertise on acute stroke care in the study
hospital; they play central roles as either acute stroke
care providers or supervisors of the delivery of acute
stroke care in the hospital. Their inclusion was also in-
formed by the fact most play a role in making strategic
decisions in the organisation of acute stroke care. All re-
spondents were full time regular employees of the study
sites. Part-time employees and resident physicians were
not eligible. Administrative or other staff whose roles are
not directly involved in the provision of acute stroke
care to patients were also excluded.
Sampling and recruitment
We employed a non-probabilistic purposive sampling
technique to recruit respondents with one respondent
per hospital. All study hospitals were formally contacted
and their participation solicited using an official letter of
invitation with information about the study, researchers
and all ethical approval letters. The invitation letter also
included a detailed study protocol and a study statement
outlining the study purpose, potential study benefits,
and an estimated time for survey completion. Prior to
recruitment and actual data collection, discussions were
held with the health administrators, clinical coordina-
tors, regional human resource managers, medical direc-
tors and heads of department to select appropriate
respondents. Consequently, one eligible respondent per
study site was selected and contacted directly by the first
author to organise the survey administration.
Data collection
An interviewer-administered survey approach was con-
ducted in respondents’ offices, clinic rooms and wards
of each hospital. This approach was chosen to enhance
response and compliance rates, provide opportunity for
concepts and questions to be clarified and to ensure ap-
propriate responses were elicited [40, 41].
The survey instrument (Additional file 1) was adapted
from a previous national survey used in Australia [42]. A
review of other relevant studies on acute stroke care
quality indicators [25, 43–45] also informed the content
of this instrument. The instrument was a paper-based,
structured questionnaire containing 80-question items
which required respondents to provide responses on the
range of hospital-based services provided to acute stroke
patients. The questionnaire was written and adminis-
tered in English. Questions were mostly closed ended
in nature and categorised into eight sections. These in-
cluded information on respondents’ professional back-
ground and qualification, characteristics of study sites,
institutional services and arrangements to support early
presentation of acute stroke patients, and data on diag-
nosis, assessment services and stroke clinical guide-
lines. The remaining sections collected information on
available acute stroke services and treatments, the
stroke care workforce, key institutional policies, prac-
tices and interventions to support acute stroke care and
on key challenges to acute stroke care.
Quality control
The survey tool was pre-tested in six non-study sites
among six acute stroke care physicians, representing two
each from the southern, middle and northern belt of
Table 1 Characteristics of study hospitals and respondents
Hospital 2014 stroke
admissions
Hospital bed
capacity
Survey respondents
TH1 1500 653 Consultant Neurologist
TH2 1000 650 Neurologist
TH3 118 500 Physician Specialist
TH4 125 400 Medical Officer
RH1 409 194 Medical Officer
RH2 313 358 Medical Officer
RH3 - 250 Physician Specialist
RH4 520 235 Physician Specialist
RH5 71 400 Senior Medical Officer
RH6 39 226 Senior Medical Officer
RH7 49 200 Senior Medical Officer
Total 11
TH Tertiary (Teaching) Hospital, RH Regional Hospital
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Ghana to account for the varied geo-political and socio-
economic development differences. This process also
tested the instrument’s suitability and relevance to the
study settings, assess adequacy of response categories
and whether all questions were appropriate within the
study context [40, 41, 46]. The instrument was accord-
ingly revised. Additionally, preliminary survey results
were sent back to individual respondents for validation
to ensure the data reflected their earlier responses.
Data analysis
Analyses were conducted using the Statistical Package for
the Social Sciences (SPSS) Version 22.0. Findings from the
analysis were reported in the forms of numbers and per-
centages displayed in tables with scores underlying the
availability of acute stroke care service and according to
the study sites. Analysis also highlighted variances in avail-
able acute stroke services across the study hospitals. The
World Stroke Society stroke service guideline [25] was
used as a reference to evaluate the extent to which
available services align with global best practice
recommendations.
Results
Respondents included four female and seven male acute
stroke care providers, comprising Consultant Neurolo-
gist (1), Neurologist (1), Physician Specialist (3), Senior
Medical Officer (3) and Medical Officer (3). Participants’
clinical practice experience ranged from three to twenty
years. Table 1 presents the characteristics of the study
hospitals and respondents. The next section presents the
results from the survey as displayed in Table 2.
Acute stroke presentation in hospitals
All participating hospitals have designated accident and
emergency departments where acute stroke patients are
first triaged. Only 9.1% of the hospitals reported the ex-
istence of locally developed protocols to support rapid
triage of stroke patients. Both local ambulance services
and private cars/taxis are used to transport acute stroke
patients to hospital, with respondents indicating the pre-
dominant means of transport being commercial vehicles
(taxi/cab). Local ambulance services were mostly used
when patients were referred from another hospitals.
Acute stroke diagnosis and assessment services
Available diagnostic and assessment services were di-
verse. Although 72.7% (8) of the study hospitals indi-
cated the availability of a CT scan, only 63.6% (7) of
these major referral hospitals had functional CT scan
machines at the time of the survey. Access to brain CT
scanning was only available 24 h/7 days in only 18.2%
(2) of the study sites, whilst the rest only had access to
these services during weekdays from 9 am–5 pm.
Availability of MRI scan services and other advanced
neurovascular diagnostic services such as electroenceph-
alogram and interventional radiology were very limited
(See Table 2). The survey showed only 36.4% (4) of the
hospitals indicated the availability of MRI scanning ser-
vices although only 27% (3) hospitals had functional
MRI services. These services were only available only on
weekdays from 9 am–5 pm. Carotid Doppler services
were available in 3 hospitals with similar limited access
during weekdays. None of the hospitals had specific
stroke clinical guidelines. Instead, a general guideline for
all health conditions known as the standard treatment
guideline from which some guidelines on acute stroke
care are embedded was available. Observations were
made by the first author to ascertain the availability of
CT and MRI brain scanning services in those study
hospitals.
Acute stroke care interventions and services
The survey revealed only 9.1% (1) of the study sites was
reported to have a stroke unit. All hospitals had general
medical wards for admissions and continuous in-patient
care post-accident and emergency wards. Although ele-
ments of a multidisciplinary team for acute stroke care
were evident, no functional and standardised one was re-
ported in any of the hospitals. Furthermore, no provision
of thrombolysis using tissue plasminogen activator for
acute ischemic stroke care was reported in any of the
study sites although 6 of respondents acknowledged
awareness of this therapy. This absence was attributed to
limited skilled personnel, cost and lack of national and
organisational (hospital) level support to provide this
therapy. In contrast, the use of aspirin for acute ischemic
stroke was reported in all the hospitals. Surgical proce-
dures for acute stroke care such as revascularization, de-
compressive craniotomy, arteriovenous malformation
treatment, surgery for aneurysm treatment were not
conducted in any of the study hospitals.
Stroke care workforce
Specialist health workforce for acute stroke care was
limited from the study. For example, the results showed
only 36.4% (4) of the hospitals reported having a neur-
ologist as part of the acute stroke care team whereas
27.3% (3) of the hospitals also indicated the availability
of a neurosurgeon to their acute stroke care workforce.
Other medical specialities (physician specialists) were re-
ported in 72.7% (8) of the study sites. The availability of
a speech therapists, occupational therapists and stroke
nurses or stroke care coordinators was not reported in
any of the study hospital. On the other hand, the avail-
ability of other acute stroke care staff in the study hospi-
tals was within appreciable levels. All hospitals reported
having medical doctors, nurses, physiotherapists and
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Table 2 Stroke services and availability in study hospitals
Thematic areas Stroke services evaluated Hospital response to available stroke services
Tertiary-Teaching
Hospitals (n = 4)
Regional Hospital
(n = 7)
Overall Total
(n = 11) %
Acute Presentation of stroke Accident and Emergency Department 4 7 11 (100.0%)
Local emergency department protocols
for rapid triage
1 0 1 (9.1%)
Common means of stroke patient
transport to hospital
− Local ambulance services 0 0 0 (0.0%)
− Taxi/Private transport arrangement 4 7 11 (100.0%)
Diagnosis and Assessment Services Functional CT Scan Service 3 4 7 (63.6%)
CT scanner (24/7) 2 0 2 (18.2%)
CT scanner (weekdays 9 am–5 am) 2 4 6 (54.5%)
Functional MRI Scan Service 3 1 4 (36.4%)
MRI (24/7) 0 0 0 (0.0%)
MRI (weekdays 9 am–5 am) 3 1 4 (36.4%)
Electrocardiogram (ECG) 4 5 9 (81.8%)
Electroencephalogram 2 0 2 (18.2%)
Neurovascular ultrasound diagnostic
services e.g. Carotid Doppler Services
2 1 3 (27.3%)
Magnetic Resonance Angiography 3 0 3 (27.3%)
Computed Tomographic Angiography 4 4 8 (72.7%)
National Institute of Health Stroke
Scale (NIHSS)
2 2 4 (100.0%)
Acute Stroke services, treatments and
rehabilitation services
Dedicated stroke unit (ward) 1 0 1 (9.1%)
General (Medical) Ward 4 7 11 (100.0%)
Multidisciplinary stroke care team 0 0 0 (0.0%)
Thrombolytic therapy (t-PA) 0 0 0 (100.0%)
Aspirin (antiplatelet) 4 7 11 (100.0%)
Early discharge care plans 4 7 11 (100.0%)
Revascularization (Carotid Endarterectomy) 0 0 0 (0.0%)
Decompressive surgery (craniotomy) 0 0 0 (0.0%)
Arteriovenous Malformation Treatment 0 0 0 (0.0%)
Surgery for Aneurysm 0 0 0 (0.0%)
On site rehabilitation services 4 7 11 (100.0%)
Stroke care workforce Clinical psychologist 4 4 8 (72.7%)
Trained Stroke Nurses 1 0 1 (9.1%)
Physician Specialist 4 4 8 (72.7%)
Neurosurgeon 3 0 3 (27.3%)
Medical Officer 4 7 11 (100.0%)
Nurse 4 7 11 (100.0%)
Neurologist 3 1 4 (36.4%)
Emergency department staff 4 7 11 (100.0%)
Stroke care coordinator 0 0 0 (0.0%)
Occupational therapist 0 0 0 (0.0%)
Physiotherapist 4 7 11 (100.0%)
Speech pathologist 0 0 0 (0.0%)
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emergency department staff. In addition, clinical psy-
chologists and social workers were also found in seven
of the eleven hospitals.
Health policy support for stroke care
Respondents indicated no direct health policy support
from the state or national level for stroke care, or a na-
tional stroke policy framework, or national stroke clinical
guideline existed. The common form of state support was
a broad-based support for improvement of care across all
hospital units and health conditions. Respondents re-
ported that a national policy on non-communicable dis-
eases existed but was yet to be operationalised as a full
national policy framework due to lack of political will. On
available opportunities for staff professional development
and stroke care quality improvement programs, respon-
dents reported that although all hospitals had policies to
support staff develop professionally, these were not being
implemented due to lack of funds. Only two hospitals had
a stroke-specific database although all hospitals had a
common database for all health conditions. No national
level or hospital level community stroke awareness pro-
grams were reported.
Discussion
To our knowledge, this is the first study to present infor-
mation on the availability of best practice hospital level
facilities for acute stroke services in Ghana. Importantly,
the results from this study has clarified current uncer-
tainties and speculation about the extent of evidence-
based practice uptake for stroke care in a LMIC. Overall,
the results suggest a limited adoption of evidence-based
acute stroke care interventions, with the provision of a
stroke unit care in only a single study hospital and no
reported application of thrombolytic therapy as well as
limited access to surgical procedures for acute stroke
treatment. However, the use of aspirin for acute ische-
mic stroke was common to all study sites. Brain scan-
ning services especially CT scans were often available
but underutilised due to high cost of access. On the
other hand, access to MRI and other advanced diagnos-
tic services were more limited in the regional hospitals.
Overall, national and hospital level health policy initia-
tives to support acute stroke care specifically were lim-
ited. This study also demonstrated that despite overall
shortages in the specialist health workforce for acute
stroke (especially neurologists), shortage of specialists
were more predominant in the regional hospitals than
the teaching hospitals.
Globally, emergency transport systems via ambulance
and other emergency medical transport services are re-
ported to support early and safe arrival for immediate
provision of appropriate care to facilitate optimal patient
health outcomes [47, 48]. However, the use of taxis or
private cars was the commonest means of transport to
hospitals by stroke patients in the present study, a
Table 2 Stroke services and availability in study hospitals (Continued)
Social worker 4 7 11 (100.0%)
Dietician 4 7 11 (100.0%)
Health policy support for stroke care Staff professional development and
quality improvement for stroke care
0 0 0 (0.0%)
National level support/ policies for
stroke care
− High 0 0 0 (0.0%)
− Average 0 0 0 (0.0%)
− Low 0 0 0 (0.0%)
− No support 4 7 11 (100.0%)
Hospital level support/policies for
stroke care
− High 0 0 0 (0.0%)
− Average 0 2 2 (18.2%)
− Low 2 1 3 (27.3%)
− No support 2 4 6 (54.5%)
Stroke register/Database 2 0 2 (18.2%)
Community/hospital stroke awareness
program
0 0 0 (0.0%)
Access to community stroke rehabilitative
programs
0 0 0 (0.0%)
Note: The listed numbers within the body of the tables indicate a “yes” answer
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situation which may lead to considerable delays in pa-
tient arrival for care. This has the potential to comprom-
ise prompt and safe responses for acute stroke patients
in the major referral hospitals. Although this study re-
ported the presence of a stroke unit in only one study
hospital, this finding further corroborates previous re-
ports indicating the limited provision of stroke unit care
in LMIC [26, 27]. The stroke unit that was reported in
this study is a six-bed capacity unit, found within a lar-
ger medical ward. Given the finding of only a single
stroke unit of the eleven major referral hospitals in this
study, it means the general medical wards represented
the predominant acute stroke care wards despite evi-
dence of less optimal patient outcomes compared to a
stroke unit [19].
Additionally, evidence of no provision of thrombolytic
therapy from the study finding supports earlier studies
asserting the limited uptake of this treatment option in
LMIC [28, 49, 50]. This requires policy attention to sup-
port the provision of thrombolytic therapy in these
major referral hospitals in view of the substantial effects
of this therapy on stroke survival. The widespread use of
aspirin therapy by all study hospitals for acute stroke
care may reflect this intervention as an inexpensive choice
and easy to administer in clinical settings [51, 52]. The up-
take of aspirin could further be maximised with enhanced
access to brain scanning devices to ensure eligible patients
are treated with aspirin.
Although seven of eleven study sites provided brain
CT scan services, access was limited only to weekdays
(9 am–5 pm). This has important implications for early
access to appropriate care given that improved patient
outcomes are often time-dependent [53]. This highlights
the need for improved access to brain imaging services
in hospitals, especially regional, because most stroke pa-
tients are likely to be treated in non-teaching hospitals
before they are referred to tertiary teaching hospitals.
The importance of this is heightened by the fact that pa-
tient referral to such tertiary hospitals is however largely
dependent on the financial capacity of the patient. Al-
though there is still lack of clarity on the direct influence
of access to brain CT scanning services on mortality and
morbidity, without early access to brain scan services,
there is high potential for inappropriate provision of care
to patients (e.g. inadvertent administration of aspirin
therapy to a haemorrhagic stroke patient).
The considerable deficit in the human resource cap-
acity to treat acute stroke patients in all study sites, es-
pecially in regional hospitals, is also noteworthy. Acute
stroke care by a neurologist was limited to four of eleven
study hospitals whilst care provided by occupational and
speech therapists were not reported in any of the hospi-
tals. This gap will likely inhibit effective patient evalu-
ation for impairment and disability. For example, given
that the incidence of dysphasia following an acute stroke
is around 37–78% [54], the absence of speech therapist
to conduct effective assessment and support likely com-
promises the quality of life of stroke patients with dys-
phasia. These results reaffirm the limited availability of
acute stroke care workforce asserted in previous studies
[55–57]. In a key report [57] outlining the principal chal-
lenges compromising global efforts to control the in-
creasing burden of non-communicable diseases such as
stroke, the issue of inadequate skilled health work force
was highlighted. This indicates an important gap in the
capacity of the health care systems to provide acute
stroke care, although regional hospitals require more
policy attention, particularly via rehabilitative specialists,
neurologists, neurosurgeons and other stroke specialists
to support optimal recovery in view of reduced in-patient
stroke mortality and dependency at discharge following
treatment by neurologists [58]. As demonstrated in
Nigeria [59], in sub-Saharan Africa, a study on task shift-
ing of specialist stroke work force roles to non-specialists
demonstrated improved knowledge on acute stroke care
and so this could be explored by the Ghanaian health pol-
icy makers and managers as a short term measure to ad-
dress the current stroke workforce deficit.
The absence of national level support for acute stroke
care, limited funding from hospital management, no com-
munity/hospital stroke awareness program, and state sup-
ported community stroke rehabilitative programs reported
in this study raises important health policy questions
about the state’s readiness and commitment to reducing
the increasing stroke burden. Long-term and community-
level care after in-patient care remains largely a family
responsibility in the absence of a community level re-
habilitative care. This augments earlier reports of limited
health policy commitment to address the current disease
burden posed by stroke and other non-communicable dis-
eases in Ghana [39, 60–63]. It also concurs with reports of
low prioritization of stroke care in the health policy
agendas of most LMIC [64–67]. Contextualising this
within the global health policy support for stroke, the
deficit in health policy support in this study under-
scores previous reports of inadequate global health
funding for stroke and other non-communicable dis-
eases [3, 68]. For example, the Institute for Health
Metrics and Evaluation recently reported that only
1.3% of overall donor support for health was allocated
to NCDs in 2015 [68]. As demonstrated in some
other LMIC [69, 70], the capacity of Ghanaian health
systems could be improved to address the growing
stroke burden by increasing funding and infrastruc-
tural support, training for more stroke specialists, for-
mulating evidence-informed policies, plans, treatment
guidelines and strategies to support effective acute
stroke diagnosis and treatment.
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Table 3 World Stroke Organization checklist for health service capacity for acute stroke care
Component of acute stroke service Service availability
Tertiary-Teaching
Hospitals (n = 4)
Regional Hospital
(n = 7)
Overall Total
(n = 11) %
Advanced stroke services
Access to advanced diagnostic services
− Magnetic Resonance Angiography 3 0 3 (27.3%)
− Computed Tomographic Angiography 4 4 8 (72.7%)
− Electroencephalogram 0 0 0 (0.0%)
− Electrocardiogram (ECG) 4 5 9 (81.8%)
− Neurovascular ultrasound diagnostic services, e.g. Carotid Doppler Services 3 0 3 (27.3%)
− Magnetic Resonance Imaging 4 1 5 (45.5%)
− Computed Tomographic Scan 4 4 8 (72.7%)
Access to physicians with stroke expertise (and physician specialists)
− Neurologists 3 1 4 (36.4%)
− Neurosurgeon 3 0 3 (27.3%)
− Physician Specialist 4 4 8 (72.7%)
Access to advanced acute stroke care interventions
− Stroke unit care 1 0 1 (9.1%)
− Tissue plasminogen activator (t-PA) 0 0 0 (0.0%)
− Decompressive surgery 0 0 0 (0.0%)
− Arteriovenous Malformation Treatment 0 0 0 (0.0%)
Surgery for Aneurysm 0 0 0 (0.0%)
Revascularization (Carotid Endarterectomy) 0 0 0 (0.0%)
Access to specialist rehabilitation therapists
− Physiotherapists 4 7 11 (100.0%)
− Occupational Therapists 0 0 0 (0.0%)
− Speech Therapists 0 0 0 (0.0%)
Access to community programs for recovery after stroke 0 0 0 (0.0%)
Essential stroke services
Access to basic diagnostic services
− Laboratory 4 7 11 (100.0%)
− ECG 4 5 9 (81.8%)
− Computed Tomographic Scan (CT scan) 4 4 8 (72.7%)
− Neurovascular ultrasound diagnostic services 3 0 3 (27.3%)
− National Institutes of Health Stroke Scale (NIH) 2 2 2 (18.2%)
Access to nurses 4 7 11 (100.0%)
Access to physicians, not necessarily stroke specialists 4 7 11 (100.0%)
Access to acute thrombolysis with t-PA 0 0 0 (0.0%)
Access to stroke unit care 1 0 1 (9.1%)
Antiplatelet (Aspirin) therapy 4 7 11 (100.0%)
Access to rehabilitation services 4 7 11 (100.0%)
Minimal healthcare services
Variable access to healthcare workers (nurses or lay workers) 4 7 11 (100.0%)
Very limited access to physicians 0 2 2 (18.2%)
No access to diagnostic services or hospital care 0 0 0 (0.0%)
Care provided in local communities 0 0 0 (0.0%)
Note: The listed numbers within the body of the tables indicate a “yes” answer
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The historical development gap between northern
Ghana and the rest was also evident in the inequitable dis-
tribution of stroke services across the study sites. Overall,
the tertiary hospitals were much more equipped with
modern stroke services to support standard care com-
pared to the regional hospitals. However, the major refer-
ral hospitals in the northern part of Ghana recorded
limited evidence-based acute stroke services. For example,
apart from the single tertiary hospital in northern Ghana,
the other two northern regional hospitals do not have CT,
MRI brain scanning services or a neurologist. This finding
reinforces earlier reports of limited access to health care
facilities in the northern parts of Ghana and has often re-
sulted in poor health outcomes compared to the other
parts of Ghana [39, 71, 72]. To address this, an affirmative
action in the form of health policy reforms to address this
situation will be in the right direction.
Based on the global stroke services guideline for stroke
care proposed by the World Stroke Society [25] as re-
ported in Table 3, this study suggests an overall limitation
in the capacity of the health care system in both teaching
and regional hospitals to provide advanced evidence-
based acute stroke services. The present study results
shows the major tertiary - teaching hospitals have more
capacity to provide most of the essential elements of the
evidence-based acute stroke care recommendation com-
pared to the regional hospitals despite the fact that re-
gional hospitals first receive most of the acute stroke cases
before likely referring to a teaching hospital. In general,
the current results underline the overarching scope and
need to improve evidence-based practice for acute stroke
care in resource poor countries such as Ghana.
Strengths and limitations
This study is the first to inform on availability of
evidence-based acute stroke care interventions in Ghana.
An added strength relates to its focus on regional and
tertiary-teaching hospitals being the major referral hos-
pitals in each administrative region in Ghana, gives the
study a national character with potential generalizable
results and relevance to other low-middle income settings.
However, this was a descriptive study which limited our
ability to evaluate the effects of these services on patient
clinical outcomes. This study was also limited in scope by
restriction to eleven public regional and teaching hospitals
and excluding private and non-regional hospitals. Future
studies should focus on both public and private hospitals
to achieve better representation.
Conclusion
A growing body of evidence on effective acute stroke
care interventions exist. However, results from this study
highlight limited access to these services especially in
the regional non-tertiary teaching hospitals. Significant
effort is required to ensure acute stroke patients access
the best care not only in tertiary but also regional hospi-
tals given that not all acute stroke patients can afford
care in teaching hospitals.
Based on this study, it is clear Ghana is yet to ad-
equately translate in health policy wise its global com-
mitments to reducing the global burden of stroke. An
overall improvement in national policy for stroke care is
needed. This should be well targeted and equity-based
given the significant disparities found across these major
referral hospitals in our study. With current projections
of a global rise in stroke incidence and the increasing
aging population, demand for acute stroke care will in-
evitably witness further increase and so there is consid-
erable scope to improve acute stroke care in low middle
income countries such as Ghana in order to minimise
premature stroke-related mortality and disability.
Additional file
Additional file 1: Survey Instrument: Acute Stroke Care Services in
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